François-Clément Bidard, M. ychou, J. Madic, A. Saliou, O. Bouche, et al.. Circulating tumor DNA and circulating tumor cells as predictor of outcome in the PRODIGE14-ACCORD21-METHEP2 phase II trial.
the 41st ESMO Congress (ESMO 2016), the European Society for Medical Oncology, Oct 2016, Copenhague, Denmark. pp.456O,
⟨10.1093/annonc/mdw370.5⟩.
⟨hal-01490996⟩